XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial Австралия - английский - Department of Health (Therapeutic Goods Administration)

xembify normal immunoglobulin 4 g/20 ml (20%) solution for subcutaneous injection vial

grifols australia pty ltd - human immunoglobulin g, quantity: 3600 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

XEMBIFY normal immunoglobulin 2 g/10 mL (20%) solution for subcutaneous injection vial Австралия - английский - Department of Health (Therapeutic Goods Administration)

xembify normal immunoglobulin 2 g/10 ml (20%) solution for subcutaneous injection vial

grifols australia pty ltd - human immunoglobulin g, quantity: 1800 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.

Flebogamma 10% DIF Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

flebogamma 10% dif

pharmaco (nz) ltd - normal immunoglobulin 100 mg/ml - solution for infusion - 100 g/l - active: normal immunoglobulin 100 mg/ml excipient: sorbitol water for injection - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillan barre syndrome. - kawasaki disease.

Sugammadex Medichem 100 mg/mL solution for injection (2 ml vial) Мальта - английский - Malta Medicines Authority

sugammadex medichem 100 mg/ml solution for injection (2 ml vial)

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - sugammadex - solution for injection - sugammadex 200 mg - all other therapeutic products

Sugammadex Medichem 100 mg/mL solution for injection (5 ml vial) Мальта - английский - Malta Medicines Authority

sugammadex medichem 100 mg/ml solution for injection (5 ml vial)

medichem, s.a. fructuós gelabert 6-8, 08970, sant joan despí, (barcellona), spain - sugammadex - solution for injection - sugammadex 500 mg - all other therapeutic products

Sugammadex Pharmazac Solution for Injection 100mg/ml (2ml vial) Мальта - английский - Malta Medicines Authority

sugammadex pharmazac solution for injection 100mg/ml (2ml vial)

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 200 mg - all other therapeutic products

Sugammadex Pharmazac Solution for Injection 100mg/ml (5ml vial) Мальта - английский - Malta Medicines Authority

sugammadex pharmazac solution for injection 100mg/ml (5ml vial)

pharmazac, s.a. 31 naousis str., 104 47, athens,, greece - sugammadex - solution for injection - sugammadex 500 mg - all other therapeutic products

Sugammadex Piramal Европейский союз - английский - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuscular blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Gammaplex 10%100 mg/ml solution for infusion Ирландия - английский - HPRA (Health Products Regulatory Authority)

gammaplex 10%100 mg/ml solution for infusion

bio products laboratory limited - human normal immunoglobulin - solution for infusion - 100 milligram(s)/millilitre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.

INTRAGAM P immunoglobulin-normal (human) 0.6g/10mL for intravenous use injection vial Австралия - английский - Department of Health (Therapeutic Goods Administration)

intragam p immunoglobulin-normal (human) 0.6g/10ml for intravenous use injection vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 60 mg/ml - injection, solution - excipient ingredients: maltose; water for injections; human immunoglobulin a - intragam p is indicated in replacement immunoglobulin g (igg) therapy in: primary immunodeficiency; myeloma and chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; congenital acquired immune deficiency syndrome with recurrent infections. indications as at 21 july 2000: replacement igg therapy in: primary immunodeficiency; myeloma and chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; congenital acquired immune deficiency syndrome with recurrent infections. immunomodulatory therapy in: idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct platelet count; allogenic bone marrow transplantation; kawasaki disease. indications as at 25 february 2003: for replacement immunoglobulin g (igg) therapy in: primary immunodeficiency; myeloma and chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections, and; congenital acquired immune deficiency syndrome with recurrent infections. for immunomodulatory therapy in: idiopathic thrombocytopenic purpura (itp) in adults or children at high risk of bleeding or prior to surgery to correct platelet count; allogeneic bone marrow transplantation; kawasaki disease, and; guillain-barre syndrome (gbs).